Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy

Abstract

The paper analyzes the data of modern scientific literature on the new class of drugs that restore the effect of glucagon-like peptide-1 (GLP-1). According to modern concepts, the pathophysio-logical mechanisms of therapeutic action of GLP-1 analogues in patients with diabetes mellitus (DM) type 2 primarily due to their bene-ficial effects on β-cell dysfunction, whose role in the pathogenesis of DM type 2 until recently been underestimated. The main targets of GLP-1 are pancreatic islets, where it glucose-dependently stimulates production and secretion of insulin and somatostatin secretion and inhibits glucagon secretion. Furthermore, GLP-1 inhibits β-cell destruction and stimulates their proliferation, increasing their number. The article presents information on the main multicenter studies on analogues of human GLP-1, analyzes hypoglycemic effectiveness of incretins and others of their positive effects.

Authors and Affiliations

V. L. Orlenko, K. P. Zak

Keywords

Related Articles

Current Trends in Pathogenesis, Diagnosis and Prognosis of Inactive Pituitary Adenomas

The paper presents an analysis of data from 138 sources in recent years. The study of factors of the development of inactive pituitary adenomas remains one of the most urgent problems of modern medicine. The development...

Carbohydrate Metabolism Disorders in Patients with Chronic Pancreatitis

This article deals with dependence of the carbohydrate metabolism disorders on the duration of disease in patients with non-destructive chronic pancreatitis. Patients with a disease duration of up to three years we mainl...

Modern Views on the Algorithm of Management of Pregnant Women and Women in Labor with Diffuse Toxic Goiter

The article presents the modern views and data on the risk factors, mechanisms of development, clinical features and complications of diffuse toxic goiter during the pregnancy, labor, in the postpartum period and in newb...

Population Risk Factors in the Genesis of Bone Metabolism Didorders in Patients with Autoimmune Thyroiditis

The paper presents population risk factors involved in the genesis of bone metabolism disorders in patients with autoimmune thyroiditis (AIT). The results of the study of bone mineral density in patients with AIT are pro...

Efficiency of D2 Receptors Agonists in treatment of Patients with Non-Functional Pituitary Adenoma with Hereditary-Tainted Anamnesis

There were analyzed two clinical cases of non-functional pituitary adenoma with the hereditary-tainted anamnesis. The presence of the original disposition or familial-hereditary cases of non-functional pituitary adenoma...

Download PDF file
  • EP ID EP226946
  • DOI -
  • Views 52
  • Downloads 0

How To Cite

V. L. Orlenko, K. P. Zak (2014). Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy. Міжнародний ендокринологічний журнал, 4(60), 112-117. https://europub.co.uk./articles/-A-226946